NCT07372365
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
8,967 public trials
1,828 recruiting studies
Lymphatic Diseases trial results
NCT06208657
- Conditions
- Central Nervous System Neoplasms, Childhood Brain Tumor, Childhood Cancer, +18 more
- Locations
-
- John Hunter Children's Hospital Newcastle, New South Wales, Australia
- Sydney Children's Hospital, Randwick Sydney, New South Wales, Australia
- The Children's Hospital at Westmead Sydney, New South Wales, Australia
- Queensland Children's Hospital Brisbane, Queensland, Australia
NCT05371132
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT06371768
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +36 more
- Locations
-
- Duke Cancer Institute Durham, North Carolina, United States
NCT06492837
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Royal Adelaide Hospital Adelaide, Australia
- Liverpool Hospital Liverpool, Australia
- St. Vincent Hospital Melbourne Melbourne, Australia
- Princess Alexandra Hospital Woolloongabba, Australia
NCT07371182
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
- Locations
-
- The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- The Second Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
- Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China
- Zunyi Medical University Affiliated Hospital, Guizhou Provincial Children's Hospital Zunyi, Guizhou, China
Recruiting
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
NCT06248515
- Conditions
- Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +7 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- Lombardi Comprehensive Cancer Center, Georgetown University Washington D.C., District of Columbia, United States
- University of Chicago Medical Center Chicago, Illinois, United States
- John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
NCT05921253
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Stephenson Cancer Center Oklahoma City, Oklahoma, United States
- Stephenson Cancer Center- Tulsa Tulsa, Oklahoma, United States
NCT06667687
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
- Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
- Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
- START Mountain Region /ID# 267592 West Valley City, Utah, United States
- Conditions
- Acute Lymphoblastic Leukemia, High Risk, Acute Lymphoblastic Leukemia, Relapse, Acute Myeloid Leukemia, High Risk, +18 more
- Locations
-
- National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198 Moscow, Russia